Unknown

Dataset Information

0

Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy.


ABSTRACT: Coronavirus disease 2019 (COVID-19) may have a metabolic origin given strong links with risk factors such as lipids and glucose and co-morbidities such as obesity and type 2 diabetes mellitus. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein mediates viral cellular entry via the ACE2 receptor. The cytoplasmic tail of this spike protein is heavily palmitoylated. Emerging studies suggest that SARS-CoV-2 alters lipid metabolism in the lung epithelial cells by modulating peroxisome proliferator-activated receptor alpha (PPAR?), possibly contributing to lipotoxicity, inflammation and untoward respiratory effects. Disruption of this process may affect palmitoylation of SARS-CoV spike protein and thus infectivity and viral assembly. COVID-19 is also increasingly being recognized as a vascular disease, with several studies noting prominent systemic endothelial dysfunction. The pathogenesis of endothelial dysfunction may also be linked to COVID-19-mediated metabolic and inflammatory effects. Herein, exercise will be compared to fenofibrate as a possible therapeutic strategy to bolster resilience against (and help manage recovery from) COVID-19. This paper will explore the hypothesis that exercise may be a useful adjuvant in a setting of COVID-19 management/rehabilitation due to its effects on PPAR? and vascular endothelial function.

SUBMITTER: Heffernan KS 

PROVIDER: S-EPMC7430295 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy.

Heffernan Kevin S KS   Ranadive Sushant M SM   Jae Sae Young SY  

Medical hypotheses 20200817


Coronavirus disease 2019 (COVID-19) may have a metabolic origin given strong links with risk factors such as lipids and glucose and co-morbidities such as obesity and type 2 diabetes mellitus. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein mediates viral cellular entry via the ACE2 receptor. The cytoplasmic tail of this spike protein is heavily palmitoylated. Emerging studies suggest that SARS-CoV-2 alters lipid metabolism in the lung epithelial cells by modulatin  ...[more]

Similar Datasets

| S-EPMC8006198 | biostudies-literature
| S-EPMC2832848 | biostudies-literature
| S-EPMC7281404 | biostudies-literature
| S-EPMC7800714 | biostudies-literature
| S-EPMC8158531 | biostudies-literature
| S-EPMC7036118 | biostudies-literature
| S-BSST563 | biostudies-other
| S-EPMC3385049 | biostudies-literature
| S-EPMC7221369 | biostudies-literature
| S-EPMC9338522 | biostudies-literature